Emergent BioSolutions CEOs Discuss 1Q 2012 Results - Earnings Call Transcript

Emergent BioSolutions, Inc. (CBN)

1Q 2012 Earnings Call

May 3, 2012 17:00 p.m. ET


Bob Burrows – Vice President IR

Dan Abdun-Nabi – President and CEO

Don Elsey – Senior Vice President Finance and Administration, CFO

W. James Jackson, Ph.D. – Senior Vice President, CSO


Adnan Butt – RBC Capital Markets

Corey Kasimov – JP Morgan

Ian Somaiya - Piper Jaffray

Nicholas Bishop - Cowen and Company

Jim Molloy - ThinkEquity



Good day, ladies and gentlemen and welcome to the first quarter 2012 Emergent BioSolutions Incorporated Earnings Conference Call. My name is Jeff and I'll be your coordinator for today. At this time, all participants are in a listen-only mode. Later we will facilitate a question-and-answer session. (Operator Instructions) As a reminder, this conference is being recorded for replay purposes.

I would now like to turn the conference over to your host for today, Mr. Bob Burrows, Vice President of Investor Relations. You have the floor, sir.

Bob Burrows

Thank you, Jeff. Good afternoon, ladies and gentlemen. Thank you for joining us today as we discuss Emergent BioSolutions first quarter 2012 financial results. As is customary, our call today is open to all participants. In addition, the call is being recorded and is copyrighted by Emergent BioSolutions.

Joining me on the call this afternoon with prepared comments will be Dan Abdun-Nabi, our President and Chief Executive Officer and Don Elsey, our Chief Financial Officer. Additional members of our senior management will be present on the call for purposes of the Q&A session.

If you liked this article you might like

Biotech movers: Ionis Drops After GSK Bows Out of Partnership

Emergent BioSolutions (EBS) Highlighted As Weak On High Volume

New Lifetime High For Emergent BioSolutions (EBS)

New Lifetime High Reached By Emergent BioSolutions (EBS)

New Lifetime High Reached: Emergent BioSolutions (EBS)